Translational Neurodegeneration

noipornpan / Getty Images / iStock

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

Dr_Microbe / Getty Images / iStock

Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease

Articles

Recent

Content type: Research
| 26 June 2019

Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia

Authors: Qiao Wei, Hai-Lin Dong, Li-Ying Pan, Cong-Xin Chen, Yang-Tian Yan, Rou-Min Wang, Hong-Fu Li, Zhi-Jun Liu, Qing-Qing Tao and Zhi-Ying Wu
Content type: Research
| 15 June 2019

Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy

Authors: Jia-Zhen Wu, Mustafa Ardah, Caroline Haikal, Alexander Svanbergsson, Meike Diepenbroek, Nishant N. Vaikath, Wen Li, Zhan-You Wang, Tiago F. Outeiro, Omar M. El-Agnaf and Jia-Yi Li
Content type: Review
| 14 June 2019

Current progress of mitochondrial transplantation that promotes neuronal regeneration

Authors: Chu-Yuan Chang, Min-Zong Liang and Linyi Chen
Content type: Research
| 21 May 2019

NF-κB/c-Rel deficiency causes Parkinson’s disease-like prodromal symptoms and progressive pathology in mice

Authors: Edoardo Parrella, Arianna Bellucci, Vanessa Porrini, Marina Benarese, Annamaria Lanzillotta, Gaia Faustini, Francesca Longhena, Giulia Abate, Daniela Uberti and Marina Pizzi
Content type: Research
| 15 May 2019

Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease

Authors: Chen Tian, Genliang Liu, Liyan Gao, David Soltys, Catherine Pan, Tessandra Stewart, Min Shi, Zhiying Xie, Na Liu, Tao Feng and Jing Zhang

Most recent articles RSS

View all articles

Editor-in-Chief

Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China

Journal news

For new submissions from 1st January 2019, authors will need to pay an article publishing charge (APC) of £1690.00/$2400.00/€2040.00 for each article submitted and accepted for publication in the journal.

Aims and Scope

Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.

Translational Neurodegeneration

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors

Molecular targets for modulating the protein translation vital to proteostasis and neuron degeneration in Parkinson’s disease

Articles

Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia

Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy

Current progress of mitochondrial transplantation that promotes neuronal regeneration

NF-κB/c-Rel deficiency causes Parkinson’s disease-like prodromal symptoms and progressive pathology in mice

Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease

Editor-in-Chief

Journal news

Aims and Scope

Affiliated with

Annual Journal Metrics

Translational Neurodegeneration

Contact us